<DOC>
	<DOCNO>NCT01775410</DOCNO>
	<brief_summary>This prospective , multi-center , non-randomized single arm feasibility trial Wolverine OCT guide atherectomy system.The trial enroll 50 subject diagnosed peripheral vascular disease lower extremities.The primary disease must locate reference vessel diameter ≥ 2.5 mm significant enough cause moderate severe symptom warrant vascular intervention .</brief_summary>
	<brief_title>OptiCal COherence ToMography ABoard InformiNg AtherEctomy</brief_title>
	<detailed_description />
	<mesh_term>Menthol</mesh_term>
	<criteria>1 . Age ≥ 18 year old . 2 . Patient candidate percutaneous intervention peripheral vascular disease leg . 3 . Patient willing able give inform consent 4 . Documented symptomatic atherosclerotic peripheral vascular disease Rutherford Classification 25 . 5 . Reference vessel lumen proximal target lesion &gt; 2.5 mm diameter visual estimation . 6 . Subject de novo target lesion ( ) stenosis &gt; 70 % visual estimation distal profunda femoral artery . No 2 lesion may treat Wolverine device . 7 . Target lesion length &lt; 10 cm target lesion &gt; 70 % &lt; 99 % stenosed . If target lesion chronic total occlusion ( 99100 % stenosed ) , target lesion length &lt; 4 cm . 8 . Patient capable meeting requirement present followup clinic visit 30 day . 9 . At least one patent tibial runoff vessel baseline . 1 . Subject pregnant breast feeding . 2 . Rutherford Class 0 1 ( asymptomatic mild claudication ) . 3 . Rutherford Class 6 ( critical limb ischemia ) . 4 . Severe calcification target lesion . 5 . Target lesion type stent graft . 6 . Target lesion iliac artery . 7 . Target lesion stenosis &lt; 70 % . 8 . Subjects significant ( &gt; 70 % ) occlusive lesion proximal target lesion successfully treat index procedure ( upstream disease ) prior treatment target lesion . 9 . Endovascular surgical procedure perform index limb less equal 30 day prior index procedure . 10 . Planned endovascular surgical procedure 30 day index procedure . 11 . Lesion contralateral limb require intervention index procedure within 30 day index procedure . 12 . Subjects active infection whether currently treat . 13 . Hemodialysis GFR &lt; 30 mL/min creatinine level &gt; 2.5mg/dL . 14 . Evidence history intracranial gastrointestinal bleeding , intracranial aneurysm , myocardial infarction stroke within past 2 month . 15 . Evidence history aneurysmal target vessel within past 2 month . 16 . History severe trauma , fracture , major surgery biopsy parenchymal organ within past 14 day . 17 . Known allergy contrast agent medication use perform endovascular intervention adequately pretreated . 18 . Subjects antiplatelet , anticoagulant , thrombolytic therapy contraindicate . 19 . History heparininduced thrombocytopenia ( HIT ) . 20 . Uncorrectable bleed diathesis , platelet dysfunction , thrombocytopenia platelet count less 125,000/mm2 , know coagulopathy , INR &gt; 1.5 . 21 . Any thrombolytic therapy within 2 week index procedure . 22 . Any clinical and/or angiographic complication attribute use another device prior insertion Wolverine subject . 23 . Subjects legal guardian sign Informed Consent . 24 . Subjects unwilling unable comply followup study requirement . 25 . Participation study investigational device , medication , biologic agent within 30 day prior enrollment either cardiovascular study could , judgment investigator , affect result study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>